Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesCannara Biotech Inc

Cannara Biotech Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
1.87 CAD 0.00(0%)
Last update at 2026-03-04T14:30:00Z
VOLUME
21270
Market Cap
179.11M
P/E
15.58

Momentum Score

…

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.82
Low
1.88
High
52 Week Price Range
1.06
Low
2.07
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
1.87
Dividend Yield
-
Revenue TTM
112.25M
Revenue Per Share
1.22
Gross Profit TTM
48.13M
Debt / Equity
-
ROE
11.71%
Net Debt
26.82M
ROCE
16.19%
Diluted EPS TTM
0.12

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-08-31 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Type yearly yearly yearly yearly yearly
Date 2025-08-31 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Income before tax 18.10M 4.48M 6.95M 2.31M -1.53M
Minority interest - - - - 0.00M
Net income 13.08M 6.44M 6.95M 2.31M -1.53M
Selling general administrative 23.17M 19.65M 13.52M 10.03M 7.30M
Gross profit 47.10M 29.79M 27.23M 17.33M 9.57M
Reconciled depreciation 6.68M 6.35M 4.94M 3.92M 3.03M
Ebit - - - 4.82M 0.05M
Ebitda - - - 8.14M 3.06M
Operating income 21.77M 8.04M 12.02M 4.98M 0.30M
Interest expense 3.77M 4.85M 3.88M 1.92M 1.57M
Tax provision 5.02M -1.95M - - -
Interest income 0.28M 0.18M 0.24M 0.09M 0.05M
Net interest income -4.10M -5.47M -5.06M -3.22M -1.67M
Total revenue 107.20M 81.75M 57.26M 35.84M 16.29M
Total operating expenses 85.43M 73.70M 45.24M 30.87M 15.99M
Cost of revenue 60.10M 51.96M 30.03M 18.51M 6.72M
Total other income expense net 0.42M 1.91M -0.02M 0.55M -0.15M
Net income from continuing ops 13.08M 6.44M 6.95M 2.31M -1.53M
Net income applicable to common shares - - - 2.31M -1.53M
Breakdown 2025-08-31 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Type yearly yearly yearly yearly yearly
Date 2025-08-31 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Total assets 168.65M 154.72M 141.52M 125.62M 92.02M
Other current assets 2.36M 2.85M 3.06M 5.71M 1.90M
Total liab 66.43M 66.77M 61.78M 58.88M 27.91M
Total stockholder equity 102.22M 87.95M 79.74M 66.74M 64.12M
Other current liab - - - 0.05M 0.04M
Common stock - - - 83.30M 83.21M
Capital stock 89.76M 88.52M 88.80M 83.30M 83.21M
Retained earnings 0.18M -12.90M -19.34M -26.30M -28.61M
Other liab - - - 0.82M 0.71M
Other assets - - - 1.22M 1.03M
Cash 14.36M 6.62M 4.27M 12.11M 8.16M
Total current liabilities 34.20M 27.00M 21.18M 11.86M 6.83M
Net debt 26.82M 41.06M 41.34M 36.04M 12.30M
Short long term debt 13.02M 9.23M 5.97M 1.97M 0.30M
Other stockholder equity - - - 0.02M 0.10M
Property plant equipment - - - 83.40M 71.75M
Total current assets 82.16M 67.47M 51.70M 40.99M 19.25M
Net tangible assets - - - 66.74M 64.12M
Net receivables 14.11M 13.04M 10.59M 8.62M 2.97M
Long term debt 28.17M 38.45M 39.64M 46.19M 20.15M
Inventory 51.33M 40.07M 33.77M 18.98M 7.41M
Accounts payable 11.08M 9.84M 13.93M 8.80M 6.19M
Non current assets total 86.49M 87.25M 89.83M 84.63M 72.78M
Capital lease obligations 0.40M 0.65M 0.18M 0.24M 0.44M
Breakdown 2025-08-31 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Type yearly yearly yearly yearly yearly
Date 2025-08-31 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Investments -5.95M -5.19M -9.48M -15.35M -30.83M
Change to liabilities - - - 2.39M 2.64M
Total cashflows from investing activities - - - -15.35M -30.83M
Net borrowings -2.58M 1.03M - 27.58M 10.08M
Total cash from financing activities -6.32M -3.14M -3.72M 25.46M 33.25M
Change to operating activities - - - 0.02M -0.27M
Net income 13.08M 6.44M 6.95M 2.31M -1.53M
Change in cash 7.74M 2.35M -7.76M 3.96M 0.39M
Begin period cash flow 6.62M 4.27M 12.11M 8.16M 7.77M
End period cash flow 14.36M 6.62M 4.27M 12.11M 8.16M
Total cash from operating activities 20.01M 10.68M 5.44M -6.08M -2.09M
Issuance of capital stock - - - 0.00M 24.30M
Depreciation 6.68M 6.35M 4.94M 3.92M 2.87M
Other cashflows from investing activities - - - -0.31M -0.44M
Dividends paid 0.00M 0.00M 0.00M 0.00M 0.00M
Change to inventory -8.47M -3.98M -8.33M -8.23M -3.37M
Change to account receivables -1.04M -2.43M -2.05M -5.68M -2.82M
Sale purchase of stock 0.00M -0.28M -0.37M - -
Other cashflows from financing activities - - - -2.17M -1.49M
Change to netincome - - - -0.94M 0.19M
Capital expenditures 6.36M 7.47M 9.88M 15.10M 30.61M
Change in working capital -6.30M -2.50M -6.11M -11.48M -3.82M
Stock based compensation 1.19M 1.98M 1.75M 0.35M 0.33M
Other non cash items 0.74M 2.41M -2.22M -0.66M -0.17M
Free cash flow 13.65M 3.21M -4.44M -21.55M -33.17M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
LOVE
Cannara Biotech Inc		 -
-%		 1.87 15.58 - 1.60 1.56 1.71 7.06
RX
Biosyent Inc.		 0.10
0.58%		 17.25 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 -
-%		 2.00 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 -0.03
8.57%		 0.32 - - 108.48 4.41 140.29 -4.26
LSL
LSL Pharma Group Inc.		 -0.01
1.61%		 0.30 20.75 - 1.88 1.89 2.85 10.19

Profile*

Cannara Biotech Inc

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

333 Decarie Blvd., Saint-Laurent, QC, Canada, H4N 3M9

514 543 4200

https://cannara.ca

452

Name Title Year Born
Mr. Zohar Krivorot CEO & Chairman 1977
Mr. Nicholas Sosiak C.A., CPA Chief Financial Officer NA
Mr. Avi Krivorot Chief Technology Officer NA
Mr. Anthony Manouk VP of Compliance & GM NA
Mr. Brian Sherman Gen. Counsel & VP Legal Affairs NA
Mr. David Abitbol VP of Marketing NA
Ms. France Landry VP of HR NA
Ms. Julia Bouvet Chief of Staff NA
Alexander Wolfe VP of Bus. Devel. NA
Etienne Ledoux Exec. Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DHT-U
CAD 13.53
+16.44%
LIF
CAD 22.04
+8.62%
TOI
CAD 103.80
+7.09%
CRON
CAD 5.26
+6.69%
CIA
CAD 2.04
+6.25%
ITH
CAD 1.61
-34.02%
IFOS
CAD 1.65
-22.90%
TNZ
CAD 49.70
-19.58%
KEEL
CAD 2.36
-19.45%
GIL
CAD 49.36
-18.33%

Equity Sectors*

  • Basic Materials

    -2.18%

  • Communication Services

    +0.95%

  • Consumer Cyclical

    -2.25%

  • Consumer Defensive

    -0.68%

  • Energy

    -2.93%

  • Financial Services

    -2.26%

  • Healthcare

    -0.46%

  • Industrials

    -3.70%

  • Real Estate

    -0.06%

  • Technology

    -3.32%

  • Utilities

    -0.50%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…